(2023)
Differential network interactions between psychosocial factors, mental health, and health-related quality of life in women and men.
Sci Rep 13(1),
11642.
Oliver Kurzai
National Reference Center for Invasive Fungal Infections · Head Fungal Septomics · Head +49 3641 532-1347 oliver.kurzai@leibniz-hki.deCurriculum vitae
Main Research Areas
- Infection biology of human pathogenic fungi (especially Candida albicans)
- Infection biology of Neisseria meningitidis
Professional Career
Since 2017 | Chair of Medical Microbiology and Mycology, Institute for Hygiene and Microbiology, Julius Maximilians University Würzburg and head of the research group Fungal Septomics at Leibniz Institute for Natural Product Research and Infection Biology – Hans-Knöll-Institute Jena |
2009-2016 | Professor (W2) for Fungal Septomics, Friedrich-Schiller-University Jena |
2008 | Habilitation in medical microbiology, University Würzburg |
2006 | Medical specialist in microbiology, virology and infection epidemiology (Bayerische Landesärztekammer) |
2003 | Head of a working group, Institut für Hygiene und Mikrobiologie, University Würzburg |
2001-2002 | Doctor in practical training (AiP), Institut für Hygiene und Mikrobiologie, University Würzburg |
2002 | Dr. med., “summa cum laude” University Würzburg |
2001 | Staatsexamen (state examination) in human medicine, University Würzburg |
Awards · Appointments · Scientific Activities
Since 2014 | Head of the Nationales Referenzzentrums für invasive Pilzinfektionen (NRZMyk) |
Since 2013 | Board member of the Integriertes Forschungs- und Behandlungszentrum “Center for Sepsis Control and Care” (CSCC) at the University Hospital Jena |
Since 2012 | Scientific Manager of the consortium “InfectControl 2020 – New Antiinfection Strategies – Science • Society • Economy” within the BMBF-Programme “Zwanzig 20 – Partnership for Innovation” (Head: Prof. A. Brakhage) |
Since 2012 | Editor-in-chief, Medical Mycology Case Reports, member (ex officio) of the executive board of the International Society for Human & Animal Mycology (ISHAM) |
Since 2011 | Elected note taker at the Deutschsprachige Mykologische Gesellschaft DMykG |
2015-2016 | Speaker of the ZIK Septomics |
2011-2013 | Editor, Journal of Basic Microbiology |
2009 | Hans-Rieth-poster prize from the Deutschsprachige Mykologische Gesellschaft (DMykG) |
2008 | Award from the Deutsche Gesellschaft für Hygiene und Mikrobiologie |
2003 | Science award from the Unterfränkische Gedenkjahrstiftung |
2003 | Dissertation award from the medical faculty of the University Würzburg |
2002 | Becton-Dickinson PhD award from the Deutsche Gesellschaft für Hygiene und Mikrobiologie |
Publications
(2023)
Appropriate antibiotic use and antimicrobial resistance: knowledge, attitudes and behaviour of medical students and their needs and preferences for learning.
Antimicrob Resist Infect Control 12(1),
48.
(2022)
Expert recommendations for prevention and management of Candida auris transmission.
Mycoses 65(6),
590-598.
(Review)
(2022)
Automated characterisation of neutrophil activation phenotypes in ex vivo human Candida blood infections.
Comput Struct Biotechnol J 20,
2297-2308.
(2022)
(1 → 3)-β-D-Glucan-guided antifungal therapy in adults with sepsis: the CandiSep randomized clinical trial.
Intensive Care Med 48(7),
865-875.
(2022)
Acceptance of different self-sampling methods for semiweekly SARS-CoV-2 testing in asymptomatic children and childcare workers at German Day Care Centers: A nonrandomized controlled trial.
JAMA Netw Open 5(9),
e2231798.
(2022)
High Seroprevalence of SARS-CoV-2 in Preschool Children in July 2022.
Dtsch Arztebl Int 119(45),
771-772.
(2022)
β-1,3-D-glucan and galactomannan as biomarkers for the detection of invasive Geotrichum and Magnusiomyces infections: a retrospective evaluation.
J Clin Microbiol 60(1),
e0160721.
(2022)
Feasibility of SARS-CoV-2 surveillance testing among children and childcare workers at German Day Care Centers: A nonrandomized controlled trial.
JAMA Netw Open 5(1),
e2142057.
(2022)
In vitro activity of nitroxoline in antifungal-resistant Candida species isolated from the urinary tract.
Antimicrob Agents Chemother 66(6),
e0226521.